Monographie - Enoxaparin sodium

Zadnji put ažurirano :
08/05/2024

Enoxaparin sodium

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Bolentax	Meksiko
Clasina	Kolumbija
Clenox	Kolumbija, Peru
Clexan	Grčka
Clexane	Argentina, Australija, Belgija, Brazil, Čile, Egipat, Hrvatska, Iran, Irska, Japan, Južna Afrika, Kolumbija, Luksemburg, Meksiko, Nizozemska, Njemačka, Novi Zeland, Peru, Poljska, Rumunjska, Saudijska Arabija, Španjolska, Švicarska, Turska, Ujedinjeni Arapski Emirati, Velika Britanija, Venecuela
Cutenox	Peru
Dilutol	Argentina, Ekvador
Dynalin	Indija
Enoparin	Venecuela
Enoxalon	Čile
Enoxanorth	Argentina
Enoxatal	Kolumbija
Hemofagin	Čile
Heptron	Brazil
Inhixa	Njemačka
Klexane	Danska, Finska, Norveška, Švedska
Lorapine	Argentina
Lovenox	Austrija, Francuska, Kanada, S A D
Lowparin	Kolumbija
Nurox	Čile

Bibliografija : Enoxaparin sodium

	Vrsta	Publikacija
311	Časopis	Newborn AL, Kessler JM, Joyner KA. Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours. Am J Health-Syst Pharm 1996 ; 53: 167-169.
811	Časopis	Charland SL, Davis DD, Tillman DJ. Activity of enoxaparin sodium in tuberculin syringes for 10 days. Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
1893	Časopis	Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. Anti-Xa stability of diluted enoxaparin for use in pediatrics. Ann Pharmacotherapy 2004 ; 38: 569-573.
2231	Časopis	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3643	Laboratorija	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
4413	Časopis	Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J. Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution. J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.

Mentions Légales